Silk Road Medical Inc (SILK) Inventory Turnover Ratio, from second quarter 2024 to second quarter 2023, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Silk Road Medical Inc   (NASDAQ: SILK)
 

Silk Road Medical Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Silk Road Medical Inc 's inventory turnover ratio, the ratio that measures Silk Road Medical Inc 's ability to manage its supply chain, sequentially decreased to 1.69 in the second quarter 2024, which does not come as a surprise, as the Silk Road Medical Inc continue to experience headwinds, which also impact its supply chain. Silk Road Medical Inc 's average inventory processing period in the Jun 30 2024 quarter, has increased to 216 days, from 191 days, in the Mar 31 2024 quarter.

Within Healthcare sector 260 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 652 in the first quarter 2024, to 1169.

SILK Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Silk Road Medical Inc Market Share?

What is Inventory Turnover Ratio?




SILK Inventory Turnover Ratio (Jun 30 2024)
II. Quarter
(Mar 31 2024)
I. Quarter
(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
Y / Y Inventory Growth 55.67 % 77.43 % 54.85 % 8.74 % 8.24 %
Y / Y Cost of Sales Growth -7.69 % -12.18 % 13.62 % 28.92 % 44.25 %
Inventory Turnover Ratio (TTM) 1.69 1.91 2.27 2.5 2.42
SILK's Total Ranking # 1169 # 652 # 748 # 824 # 813
Average inventory processing period 215 191 161 146 151
Seq. Inventory Growth -2.64 % 2.04 % 35.39 % 15.73 % 10.97 %
Seq. Cost of Sales Growth 9.09 % -11.82 % 3.95 % -7.69 % 3.78 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 108
Healthcare Sector # 261
Overall Market # 1169

Inventory Turnover Ratio Statistics
High Average Low
2.5 1.9 0.98
(Sep 30 2023)   (Sep 30 2019)




Financial Statements
Silk Road Medical Inc 's Inventories $ 30 Millions Visit SILK's Balance sheet
Silk Road Medical Inc 's Cost of Revenues TTM $ 47 Millions Visit SILK's Income Statement
What are SILK's Sales? Visit SILK's Sales by Segment

Other Inventory Turnover Ratios
Silk Road Medical Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
SILK's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for SILK's Competitors
Inventory Turnover Ratio for SILK's Suppliers
Inventory Turnover Ratio for SILK's Customers

You may also want to know
SILK's Sales Growth Rates SILK's Pe Price to earnings ratio SILK's Receivables Turnover Ratio SILK's Stock Quote
SILK's Net Income Growth Rates SILK's Ps Price to Sales ratio SILK's Sales per Employee SILK's Asset Turnover Ratio
SILK's Net Margin SILK's Pb Price to Book ratio SILK's Financial Strength Ratios SILK's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2024, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2024 Inventories at quarter ending Jun 30 2024
Scilex Holding Company  4.39 $ 16.143  Millions$ 4  Millions
West Pharmaceutical Services Inc   4.31 $ 1,849.300  Millions$ 429  Millions
Escalon Medical Corp   4.31 $ 6.835  Millions$ 2  Millions
Envista Holdings Corporation  4.31 $ 1,150.700  Millions$ 267  Millions
Steris Plc  4.27 $ 3,085.440  Millions$ 722  Millions
Lifeward ltd   4.25 $ 15.819  Millions$ 4  Millions
Align Technology inc   4.20 $ 1,188.507  Millions$ 283  Millions
Electromedical Technologies Inc   4.18 $ 0.290  Millions$ 0  Millions
Ge Healthcare Technologies Inc   4.13 $ 8,356.000  Millions$ 2,025  Millions
Bristol myers Squibb Company  4.10 $ 11,450.000  Millions$ 2,790  Millions
Ufp Technologies Inc   4.10 $ 298.948  Millions$ 73  Millions
Integrated Biopharma Inc  4.08 $ 46.000  Millions$ 11  Millions
Organogenesis Holdings Inc   4.06 $ 112.420  Millions$ 28  Millions
Avid Bioservices Inc   4.02 $ 133.460  Millions$ 33  Millions
Blue Water Vaccines Inc  3.93 $ 2.301  Millions$ 1  Millions
Dynatronics Corporation  3.93 $ 24.899  Millions$ 6  Millions
Strata Skin Sciences Inc  3.90 $ 13.821  Millions$ 4  Millions
Idexx Laboratories Inc  3.88 $ 1,498.526  Millions$ 386  Millions
Exelixis Inc   3.78 $ 79.450  Millions$ 21  Millions
Incyte Corporation  3.76 $ 267.432  Millions$ 71  Millions
Catalyst Pharmaceuticals Inc   3.70 $ 57.901  Millions$ 16  Millions
Gilead Sciences Inc   3.68 $ 6,751.000  Millions$ 1,832  Millions
Teva Pharmaceutical Industries Limited  3.65 $ 8,227.000  Millions$ 2,256  Millions
3m Company  3.64 $ 17,158.000  Millions$ 4,711  Millions
Tactile Systems Technology Inc   3.62 $ 77.622  Millions$ 21  Millions
Lftd Partners Inc   3.59 $ 31.422  Millions$ 9  Millions
Becton Dickinson And Company  3.53 $ 11,488.000  Millions$ 3,258  Millions
Cadre Holdings inc   3.51 $ 311.529  Millions$ 89  Millions
Novocure Limited  3.37 $ 132.991  Millions$ 39  Millions
Koru Medical Systems Inc   3.33 $ 11.561  Millions$ 3  Millions

Date modified: 2026-09-08T15:11:18+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.